Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors
about
Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogsInternational Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease statesIsolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.Clinical and experimental progression of a new model of human prostate cancer and therapeutic approachHuman renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survivalGrowth hormone and prostate cancer: guilty by association?Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway.Peptide analogs in the therapy of prostate cancer.The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro.Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists.Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.Antitumorigenic actions of growth hormone-releasing hormone antagonists.Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers.Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers.Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors.Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice.Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation.Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines.
P2860
Q24292089-CD5BF951-B94C-46C2-8545-ED88362DCBCDQ24643524-AF169C86-E839-4AD8-9B41-D8C77A29D365Q24652328-30B77BF8-C896-4DA7-A476-C812774EFBE6Q24685731-AFA61D6A-EF1C-419A-8806-B86677732B89Q30454262-8E3E9AD6-46BC-49F8-B796-CDA894C6473BQ33533645-80A0269C-8E8C-44F7-9EEC-7F988F52CD95Q33708557-33CA3890-66C5-4B58-8037-2D095911E5CCQ33939652-F86EEF43-F4F7-4585-907F-2BCCD5BCA277Q34057795-6EB46C47-1448-4AD3-9842-EC18DB94F4ECQ34154583-F5C7E0F5-3DA4-479A-ADC2-FFDCF0D1D6D7Q34330174-8246F538-27ED-4719-AE97-495CD597D13AQ34785138-9334296A-BDC2-44A8-8AC7-EB5FB34D296EQ34801437-5AF2C538-3D91-4F94-B953-82B1CDB157D0Q34846722-717A64FD-78E5-4C62-B92F-09F1B917518FQ35066088-82A447DD-7363-4FDD-AE85-775EA34C2DAEQ35185769-87A16338-2FDE-4F6B-95B9-8CB428F5B495Q35629436-49903F81-C4D5-4236-A929-9502E8F93EFDQ36092731-5201C9BC-E92D-434D-ADA0-0FBBE4264B40Q36641767-3D42620F-C867-4F89-A288-C2D7412F9E0EQ36673732-46F5780E-50F8-46FC-8864-FB3D6C322B02Q36775086-39DA3DA8-7F3B-4113-B698-136EF14BF0A0Q37589369-58E4211D-F65B-4EF5-9ED8-2FA493A0539CQ38311441-9DF462C8-E571-40BE-80D1-4A4565FAEB72Q40430581-20B1006C-4361-471A-AE16-6838668931A5Q40700714-5DDD22B7-2D3F-4C75-AB80-7BF54F521269Q40869861-4512F270-51F9-4F29-82EF-44333C11C037Q44059662-1E0BDB65-2203-4AC4-B64F-A2BFDCD6635EQ52544199-759CC4F8-01BD-4D41-B365-3EE67E31EAD6
P2860
Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Growth hormone-releasing hormo ...... ike growth factor II in tumors
@ast
Growth hormone-releasing hormo ...... ike growth factor II in tumors
@en
type
label
Growth hormone-releasing hormo ...... ike growth factor II in tumors
@ast
Growth hormone-releasing hormo ...... ike growth factor II in tumors
@en
prefLabel
Growth hormone-releasing hormo ...... ike growth factor II in tumors
@ast
Growth hormone-releasing hormo ...... ike growth factor II in tumors
@en
P2093
P2860
P356
P1476
Growth hormone-releasing hormo ...... ike growth factor II in tumors
@en
P2093
P2860
P304
P356
10.1073/PNAS.95.15.8864
P407
P577
1998-07-01T00:00:00Z